Bioperfectus COVID-19 Real-time PCR Kit Excels in Clinical Performance

Company news
2020-12-14

According to College of American Pathologists, "Analytic performance of many SARS-CoV-2 diagnostic PCR tests approaches 100% at 500-5000 copies/mL; however, clinical performance of testing depends on biology and pre-analytic factors and only approaches 80% sensitivity and 98-99% specificity."


Bioperfectus Real-Time PCR Kit approaches 94.9% clinical sensitivity and 98.7% clinical specificity at 350 copies/mL with nearly 1,000 samples in clinical trials,  which is applicable and well-recognized in the PCR laboratories around the world.

MOST READ

Tick-Borne Diseases: Understanding, Prevention, and Diagnosis

Tick-borne diseases pose a substantial burden on global health, necessitating urgent attention. Addressing the challenge of tick-borne illnesses is crucial for ensuring the protection of public health worldwide.

2023-06-02

Celebrating Three Years of International Growth and Success at BioPerfectus

Today, we spotlight the remarkable journey of BioPerfectus's global footprint, a testament to our significant growth and expansion.

2023-06-01

BioPerfectus Launches New PCR Kit for STD Diagnostic Solution

BioPerfectus announces the CE marking of one new product: Herpes Simplex Virus Type I/II Real Time PCR Kit.

2023-04-27